Opthea Ltd
ASX:OPT
Opthea Ltd
Cash from Financing Activities
Opthea Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Opthea Ltd
ASX:OPT
|
Cash from Financing Activities
$138.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
Immutep Ltd
ASX:IMM
|
Cash from Financing Activities
AU$76m
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
Mesoblast Ltd
ASX:MSB
|
Cash from Financing Activities
$67.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-8%
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash from Financing Activities
-AU$2.7m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash from Financing Activities
AU$10.2m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Opthea Ltd's Cash from Financing Activities?
Cash from Financing Activities
138.5m
USD
Based on the financial report for Dec 31, 2023, Opthea Ltd's Cash from Financing Activities amounts to 138.5m USD.
What is Opthea Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
61%
Over the last year, the Cash from Financing Activities growth was -17%. The average annual Cash from Financing Activities growth rates for Opthea Ltd have been 6% over the past three years , 61% over the past five years .